UTMD
Utah Medical Products, Inc.
Price Chart
Latest Quote
$66.65
-0.82 (-1.22%)
Current Price
| Previous Close | $67.47 |
| Open | $66.23 |
| Day High | $67.42 |
| Day Low | $66.23 |
| Volume | 2,882 |
Stock Information
| Quarterly Dividend / Yield | $1.24 / 1.83% |
| Shares Outstanding | 3.18M |
| Quarterly Dividend Yield | 1.83% |
| Quarterly Dividend | $1.24 |
| Total Debt | $210K |
| Cash Equivalents | $87.41M |
| Revenue | $37.53M |
| Net Income | $10.85M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $212.22M |
| P/E Ratio | 19.72 |
| EPS (TTM) | $3.38 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $127.63M |
| Sales | $37.53M |
| Income | $10.85M |
| Book/sh | $37.43 |
| Cash/sh | $27.45 |
| Employees | 140 |
Financial Ratios
| Quick Ratio | 25.98 |
| Current Ratio | 28.64 |
| Debt/Eq | 0.17 |
| EPS Growth TTM | -14.40% |
Returns & Margins
| ROA | 6.22% |
| ROE | 9.14% |
| Gross Margin | 57.94% |
| Operating Margin | 34.47% |
| Profit Margin | 28.91% |
Ownership
| Insider Ownership | 7.18% |
| Institutional Ownership | 74.94% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 4.25 |
| P/S | 5.65 |
| P/B | 1.78 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $66.82 |
| SMA50 | $66.43 |
| SMA200 | $61.87 |
| RSI | 51.26 |
| ATR | 1.9296 |
| Shares Float | 2.77M |
| Short Float | 4.34% |
| Short Ratio | 10.97 |
| Volatility | 0.37 |
| Rel Volume | 0.28 |
Performance History
| Week | -2.84% |
| Month | +4.14% |
| Quarter | +3.49% |
| 6 Months | +17.13% |
| YTD | +18.54% |
| Year | +22.90% |
| 3 Years | -28.31% |
| 5 Years | -11.08% |
| 10 Years | +21.95% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $66.65 | 2,882 |
| 2026-06-16 | $67.47 | 12,900 |
| 2026-06-15 | $69.87 | 11,700 |
| 2026-06-12 | $67.84 | 5,000 |
| 2026-06-11 | $69.44 | 8,800 |
| 2026-06-10 | $68.60 | 13,000 |
| 2026-06-09 | $68.07 | 8,000 |
| 2026-06-08 | $67.05 | 6,800 |
| 2026-06-05 | $67.65 | 7,100 |
| 2026-06-04 | $67.99 | 7,900 |
| 2026-06-03 | $65.53 | 8,200 |
| 2026-06-02 | $66.82 | 7,100 |
| 2026-06-01 | $66.18 | 11,200 |
| 2026-05-29 | $66.45 | 7,700 |
| 2026-05-28 | $66.27 | 7,000 |
| 2026-05-27 | $65.54 | 5,900 |
| 2026-05-26 | $65.22 | 8,400 |
| 2026-05-22 | $64.51 | 10,400 |
| 2026-05-21 | $64.99 | 41,200 |
| 2026-05-20 | $64.17 | 13,400 |
| 2026-05-19 | $64.00 | 6,700 |
| 2026-05-18 | $64.00 | 7,400 |
About Utah Medical Products, Inc.
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
đ° Latest News
The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah
Zacks âĸ 2026-06-05T08:44:00Z
Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart
Zacks âĸ 2026-06-04T20:21:00Z
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
Zacks âĸ 2026-04-29T16:26:00Z
Utah Medical Gains 32% in a Year: Should You Buy the Stock?
Zacks âĸ 2026-04-16T17:38:00Z
The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products
Zacks âĸ 2026-04-02T08:17:00Z
Top Research Reports for American Express, Intuitive Surgical & Shopify
Zacks âĸ 2026-04-01T21:37:00Z
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.31
Simply Wall St. âĸ 2026-02-08T13:03:34Z
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y
Zacks âĸ 2026-02-04T17:38:00Z
Utah Medical: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-01-29T14:18:57ZUtah Medical Products, Inc.'s (NASDAQ:UTMD) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Simply Wall St. âĸ 2026-01-25T13:15:49Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $16,519,000 | $16,760,000 | $20,186,000 | $20,085,000 |
| Cost Of Revenue | $16,519,000 | $16,760,000 | $20,186,000 | $20,085,000 |
| Total Revenue | $38,520,000 | $40,903,000 | $50,224,000 | $52,281,000 |
| Operating Revenue | $38,520,000 | $40,903,000 | $50,224,000 | $52,281,000 |
| Expenses | ||||
| Total Expenses | $27,118,000 | $27,309,000 | $33,447,000 | $32,491,000 |
| Other Income Expense | $2,708,000 | $3,208,000 | $3,312,000 | $869,000 |
| Other Non Operating Income Expenses | $-100,000 | $-159,000 | $276,000 | $208,000 |
| Operating Expense | $10,599,000 | $10,549,000 | $13,261,000 | $12,406,000 |
| Selling And Marketing Expense | $2,051,000 | $1,901,000 | $1,685,000 | $1,507,000 |
| General And Administrative Expense | $7,880,000 | $7,835,000 | $11,016,000 | $10,406,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Normalized Income | $9,039,998 | $11,093,750 | $14,121,192 | $15,945,934 |
| Net Income From Continuing And Discontinued Operation | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Total Operating Income As Reported | $11,402,000 | $13,594,000 | $16,777,000 | $19,790,000 |
| Net Income Common Stockholders | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Net Income | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Net Income Including Noncontrolling Interests | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Net Income Continuous Operations | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Pretax Income | $14,110,000 | $16,802,000 | $20,089,000 | $20,659,000 |
| Operating Income | $11,402,000 | $13,594,000 | $16,777,000 | $19,790,000 |
| Gross Profit | $22,001,000 | $24,143,000 | $30,038,000 | $32,196,000 |
| Per Share | ||||
| Diluted EPS | $3.48 | $3.96 | $4.57 | $4.52 |
| Basic EPS | $3.54 | $4.16 | $4.58 | $5.69 |
| Other | ||||
| Tax Effect Of Unusual Items | $561,998 | $586,750 | $522,192 | $133,934 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $11,602,000 | $13,073,000 | $20,109,000 | $26,211,000 |
| Total Unusual Items | $2,808,000 | $3,367,000 | $3,036,000 | $661,000 |
| Total Unusual Items Excluding Goodwill | $2,808,000 | $3,367,000 | $3,036,000 | $661,000 |
| Reconciled Depreciation | $3,008,000 | $2,846,000 | $6,368,000 | $7,082,000 |
| EBITDA (Bullshit earnings) | $14,410,000 | $16,440,000 | $23,145,000 | $26,872,000 |
| EBIT | $11,402,000 | $13,594,000 | $16,777,000 | $19,790,000 |
| Diluted Average Shares | $3,240,000 | $3,503,000 | $3,637,000 | $3,643,000 |
| Basic Average Shares | $3,186,221 | $3,335,156 | $3,630,000 | $3,628,000 |
| Diluted NI Availto Com Stockholders | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Tax Provision | $2,824,000 | $2,928,000 | $3,454,000 | $4,186,000 |
| Gain On Sale Of Security | $2,808,000 | $3,367,000 | $3,036,000 | $661,000 |
| Research And Development | $668,000 | $813,000 | $560,000 | $493,000 |
| Selling General And Administration | $9,931,000 | $9,736,000 | $12,701,000 | $11,913,000 |
| Other Gand A | $7,880,000 | $7,835,000 | $11,016,000 | $10,406,000 |
Fetched: 2026-06-12
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $104,376,000 | $100,982,000 | $109,675,000 | $90,523,000 |
| Total Assets | $122,542,000 | $122,538,000 | $135,458,000 | $123,874,000 |
| Total Non Current Assets | $24,800,000 | $26,208,000 | $29,189,000 | $33,955,000 |
| Goodwill And Other Intangible Assets | $14,892,000 | $16,445,000 | $18,638,000 | $23,731,000 |
| Other Intangible Assets | $840,000 | $2,865,000 | $4,946,000 | $10,377,000 |
| Current Assets | $97,742,000 | $96,330,000 | $106,269,000 | $89,919,000 |
| Other Current Assets | $529,000 | $448,000 | $429,000 | $515,000 |
| Inventory | $7,935,000 | $8,812,000 | $9,582,000 | $8,814,000 |
| Receivables | $3,522,000 | $4,094,000 | $3,390,000 | $5,538,000 |
| Receivables Adjustments Allowances | $-515,000 | $-143,000 | $-151,000 | $-182,000 |
| Accrued Interest Receivable | $2,000 | $-2,000 | $53,000 | $51,000 |
| Accounts Receivable | $4,035,000 | $4,239,000 | $3,488,000 | $5,538,000 |
| Cash Cash Equivalents And Short Term Investments | $85,756,000 | $82,976,000 | $92,868,000 | $75,052,000 |
| Cash And Cash Equivalents | $85,756,000 | $82,976,000 | $92,868,000 | $75,052,000 |
| Cash Financial | $85,756,000 | $82,976,000 | $92,868,000 | $75,052,000 |
| Prepaid Assets | - | - | - | $515,000 |
| Debt | ||||
| Total Debt | $225,000 | $282,000 | $295,000 | $341,000 |
| Long Term Debt And Capital Lease Obligation | $225,000 | $282,000 | $295,000 | $341,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,274,000 | $5,111,000 | $7,145,000 | $9,620,000 |
| Total Non Current Liabilities Net Minority Interest | $676,000 | $1,354,000 | $2,435,000 | $3,660,000 |
| Non Current Deferred Liabilities | $451,000 | $1,072,000 | $1,442,000 | $2,063,000 |
| Non Current Deferred Taxes Liabilities | $451,000 | $1,072,000 | $1,442,000 | $2,063,000 |
| Current Liabilities | $2,598,000 | $3,757,000 | $4,710,000 | $5,960,000 |
| Payables And Accrued Expenses | $2,530,000 | $3,646,000 | $4,453,000 | $5,756,000 |
| Payables | $2,000 | $543,000 | $1,096,000 | $1,555,000 |
| Total Tax Payable | $-909,000 | $-153,000 | $327,000 | $337,000 |
| Income Tax Payable | $-909,000 | $-153,000 | $327,000 | $337,000 |
| Accounts Payable | $911,000 | $696,000 | $769,000 | $1,218,000 |
| Tradeand Other Payables Non Current | - | $0 | $698,000 | $1,256,000 |
| Equity | ||||
| Common Stock Equity | $119,268,000 | $117,427,000 | $128,313,000 | $114,254,000 |
| Total Equity Gross Minority Interest | $119,268,000 | $117,427,000 | $128,313,000 | $114,254,000 |
| Stockholders Equity | $119,268,000 | $117,427,000 | $128,313,000 | $114,254,000 |
| Gains Losses Not Affecting Retained Earnings | $-9,416,000 | $-11,908,000 | $-10,658,000 | $-12,039,000 |
| Other Equity Adjustments | $-9,416,000 | $-11,908,000 | $-10,658,000 | $-12,039,000 |
| Retained Earnings | $128,652,000 | $129,302,000 | $138,341,000 | $126,006,000 |
| Other | ||||
| Ordinary Shares Number | $3,186,221 | $3,335,156 | $3,630,000 | $3,628,000 |
| Share Issued | $3,186,221 | $3,335,156 | $3,630,000 | $3,628,000 |
| Tangible Book Value | $104,376,000 | $100,982,000 | $109,675,000 | $90,523,000 |
| Invested Capital | $119,268,000 | $117,427,000 | $128,313,000 | $114,254,000 |
| Working Capital | $95,144,000 | $92,573,000 | $101,559,000 | $83,959,000 |
| Capital Lease Obligations | $225,000 | $282,000 | $295,000 | $341,000 |
| Total Capitalization | $119,268,000 | $117,427,000 | $128,313,000 | $114,254,000 |
| Additional Paid In Capital | $0 | $0 | $594,000 | $251,000 |
| Capital Stock | $32,000 | $33,000 | $36,000 | $36,000 |
| Common Stock | $32,000 | $33,000 | $36,000 | $36,000 |
| Long Term Capital Lease Obligation | $225,000 | $282,000 | $295,000 | $341,000 |
| Current Provisions | $68,000 | $111,000 | $257,000 | $204,000 |
| Current Accrued Expenses | $2,528,000 | $3,103,000 | $3,357,000 | $4,201,000 |
| Goodwill | $14,052,000 | $13,580,000 | $13,692,000 | $13,354,000 |
| Net PPE | $9,908,000 | $9,763,000 | $10,551,000 | $10,224,000 |
| Accumulated Depreciation | $-25,339,000 | $-23,926,000 | $-23,722,000 | $-22,944,000 |
| Gross PPE | $35,247,000 | $33,689,000 | $34,273,000 | $33,168,000 |
| Construction In Progress | $110,000 | $19,000 | $1,413,000 | $906,000 |
| Machinery Furniture Equipment | $19,055,000 | $18,527,000 | $17,315,000 | $17,068,000 |
| Buildings And Improvements | $14,385,000 | $13,539,000 | $13,907,000 | $13,601,000 |
| Land And Improvements | $1,697,000 | $1,604,000 | $1,638,000 | $1,593,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,223,000 | $1,913,000 | $1,685,000 | $1,896,000 |
| Work In Process | $1,627,000 | $1,414,000 | $1,503,000 | $1,193,000 |
| Raw Materials | $5,085,000 | $5,485,000 | $6,394,000 | $5,725,000 |
| Other Properties | - | - | - | - |
Fetched: 2026-06-12
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $14,321,000 | $14,596,000 | $21,642,000 | $20,329,000 |
| Operating Activities | ||||
| Operating Cash Flow | $14,692,000 | $14,831,000 | $22,281,000 | $21,147,000 |
| Cash Flow From Continuing Operating Activities | $14,692,000 | $14,831,000 | $22,281,000 | $21,147,000 |
| Investing Activities | ||||
| Capital Expenditure | $-371,000 | $-235,000 | $-639,000 | $-818,000 |
| Investing Cash Flow | $-371,000 | $-208,000 | $-639,000 | $-818,000 |
| Cash Flow From Continuing Investing Activities | $-371,000 | $-208,000 | $-639,000 | $-818,000 |
| Capital Expenditure Reported | $-371,000 | $-235,000 | $-639,000 | $-818,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-8,355,000 | $-19,968,000 | $0 | $-2,495,000 |
| Financing Cash Flow | $-12,338,000 | $-23,838,000 | $-4,165,000 | $-5,484,000 |
| Cash Flow From Continuing Financing Activities | $-12,338,000 | $-23,838,000 | $-4,165,000 | $-5,484,000 |
| Cash Dividends Paid | $-3,983,000 | $-4,260,000 | $-4,282,000 | $-3,163,000 |
| Common Stock Dividend Paid | $-3,983,000 | $-4,260,000 | $-4,282,000 | $-3,163,000 |
| Net Common Stock Issuance | $-8,355,000 | $-19,968,000 | $0 | $-2,495,000 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $4,003,000 | $4,638,000 | $4,827,000 | $4,970,000 |
| End Cash Position | $85,756,000 | $82,976,000 | $92,868,000 | $75,052,000 |
| Beginning Cash Position | $82,976,000 | $92,868,000 | $75,052,000 | $60,974,000 |
| Effect Of Exchange Rate Changes | $797,000 | $-677,000 | $339,000 | $-767,000 |
| Changes In Cash | $1,983,000 | $-9,215,000 | $17,477,000 | $14,845,000 |
| Proceeds From Stock Option Exercised | $0 | $390,000 | $117,000 | $174,000 |
| Common Stock Payments | $-8,355,000 | $-19,968,000 | $0 | $-2,495,000 |
| Net PPE Purchase And Sale | $0 | $27,000 | $0 | $0 |
| Sale Of PPE | $0 | $27,000 | $0 | $0 |
| Change In Working Capital | $317,000 | $-1,803,000 | $-233,000 | $-2,226,000 |
| Change In Payables And Accrued Expense | $-1,157,000 | $-1,577,000 | $-1,878,000 | $716,000 |
| Change In Accrued Expense | $-1,368,000 | $-1,504,000 | $-1,422,000 | $252,000 |
| Change In Payable | $211,000 | $-73,000 | $-456,000 | $464,000 |
| Change In Account Payable | $211,000 | $-73,000 | $-456,000 | $464,000 |
| Change In Prepaid Assets | $-54,000 | $-32,000 | $45,000 | $-64,000 |
| Change In Inventory | $1,195,000 | $587,000 | $-670,000 | $-2,353,000 |
| Change In Receivables | $333,000 | $-781,000 | $2,270,000 | $-525,000 |
| Changes In Account Receivables | $338,000 | $-835,000 | $2,270,000 | $-511,000 |
| Stock Based Compensation | $373,000 | $256,000 | $225,000 | $183,000 |
| Provisionand Write Offof Assets | $367,000 | $-4,000 | $-33,000 | $30,000 |
| Deferred Tax | $-659,000 | $-338,000 | $-681,000 | $-395,000 |
| Deferred Income Tax | $-659,000 | $-338,000 | $-681,000 | $-395,000 |
| Depreciation Amortization Depletion | $3,008,000 | $2,846,000 | $6,368,000 | $7,082,000 |
| Depreciation And Amortization | $3,008,000 | $2,846,000 | $6,368,000 | $7,082,000 |
| Amortization Cash Flow | $2,126,000 | $2,065,000 | $5,692,000 | $6,417,000 |
| Amortization Of Intangibles | $2,126,000 | $2,065,000 | $5,692,000 | $6,417,000 |
| Depreciation | $882,000 | $781,000 | $676,000 | $665,000 |
| Net Income From Continuing Operations | $11,286,000 | $13,874,000 | $16,635,000 | $16,473,000 |
| Excess Tax Benefit From Stock Based Compensation | - | - | $12,000 | $6,000 |
| Purchase Of PPE | - | - | - | $-809,000 |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
| Change In Tax Payable | - | - | - | - |
| Change In Income Tax Payable | - | - | - | - |
Fetched: 2026-06-12